141 related articles for article (PubMed ID: 31090230)
1. Associations of telomere length in risk and recurrence of prostate cancer: A meta-analysis.
Hu R; Hua XG; Jiang QC
Andrologia; 2019 Aug; 51(7):e13304. PubMed ID: 31090230
[TBL] [Abstract][Full Text] [Related]
2. Prostate stromal cell telomere shortening is associated with risk of prostate cancer in the placebo arm of the Prostate Cancer Prevention Trial.
Heaphy CM; Gaonkar G; Peskoe SB; Joshu CE; De Marzo AM; Lucia MS; Goodman PJ; Lippman SM; Thompson IM; Platz EA; Meeker AK
Prostate; 2015 Aug; 75(11):1160-6. PubMed ID: 25893825
[TBL] [Abstract][Full Text] [Related]
3. Genetic variants in the TEP1 gene are associated with prostate cancer risk and recurrence.
Gu C; Li Q; Zhu Y; Qu Y; Zhang G; Wang M; Yang Y; Wang J; Jin L; Wei Q; Ye D
Prostate Cancer Prostatic Dis; 2015 Dec; 18(4):310-6. PubMed ID: 26238235
[TBL] [Abstract][Full Text] [Related]
4. Can telomere alterations predict biochemical recurrence in prostate adenocarcinoma? A preliminary study.
Baydar DE; Ozen H; Geyik PO; Gurel B
Pathol Res Pract; 2010 Oct; 206(10):700-4. PubMed ID: 20674190
[TBL] [Abstract][Full Text] [Related]
5. The impact of telomere length on prostate cancer aggressiveness, genomic instability and health disparities.
Huang R; Bornman MSR; Stricker PD; Simoni Brum I; Mutambirwa SBA; Jaratlerdsiri W; Hayes VM
Sci Rep; 2024 Apr; 14(1):7706. PubMed ID: 38565642
[TBL] [Abstract][Full Text] [Related]
6. Prediagnostic Obesity and Physical Inactivity Are Associated with Shorter Telomere Length in Prostate Stromal Cells.
Joshu CE; Peskoe SB; Heaphy CM; Kenfield SA; Van Blarigan EL; Mucci LA; Giovannucci EL; Stampfer MJ; Yoon G; Lee TK; Hicks JL; De Marzo AM; Meeker AK; Platz EA
Cancer Prev Res (Phila); 2015 Aug; 8(8):737-42. PubMed ID: 25990087
[TBL] [Abstract][Full Text] [Related]
7. Obesity is Associated with Shorter Telomere Length in Prostate Stromal Cells in Men with Aggressive Prostate Cancer.
Joshu CE; Heaphy CM; Barber JR; Lu J; Zarinshenas R; Davis C; Han M; Lotan TL; Sfanos KS; De Marzo AM; Meeker AK; Platz EA
Cancer Prev Res (Phila); 2021 Apr; 14(4):463-470. PubMed ID: 33355185
[TBL] [Abstract][Full Text] [Related]
8. Telomere length in multiple cancer: insight into recurrence risk from a meta-analysis.
Gao M; Zheng G; Li Y; Zhang Y; Hu P; Pan Y
J Gastroenterol Hepatol; 2023 Jun; 38(6):844-853. PubMed ID: 36999210
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer cell telomere length variability and stromal cell telomere length as prognostic markers for metastasis and death.
Heaphy CM; Yoon GS; Peskoe SB; Joshu CE; Lee TK; Giovannucci E; Mucci LA; Kenfield SA; Stampfer MJ; Hicks JL; De Marzo AM; Platz EA; Meeker AK
Cancer Discov; 2013 Oct; 3(10):1130-41. PubMed ID: 23779129
[TBL] [Abstract][Full Text] [Related]
10. Telomere length as a risk factor for hereditary prostate cancer.
Hurwitz LM; Heaphy CM; Joshu CE; Isaacs WB; Konishi Y; De Marzo AM; Isaacs SD; Wiley KE; Platz EA; Meeker AK
Prostate; 2014 Apr; 74(4):359-64. PubMed ID: 24285042
[TBL] [Abstract][Full Text] [Related]
11. Telomere Length and Breast Cancer Prognosis: A Systematic Review.
Ennour-Idrissi K; Maunsell E; Diorio C
Cancer Epidemiol Biomarkers Prev; 2017 Jan; 26(1):3-10. PubMed ID: 27677729
[TBL] [Abstract][Full Text] [Related]
12. Long leukocyte telomere length in prostate cancer patients at diagnosis is associated with poor metastasis-free and cancer-specific survival.
Svenson U; Roos G; Wikström P
Tumour Biol; 2017 Feb; 39(2):1010428317692236. PubMed ID: 28222672
[TBL] [Abstract][Full Text] [Related]
13. Circulating leukocyte telomere length and risk of overall and aggressive prostate cancer.
Julin B; Shui I; Heaphy CM; Joshu CE; Meeker AK; Giovannucci E; De Vivo I; Platz EA
Br J Cancer; 2015 Feb; 112(4):769-76. PubMed ID: 25562437
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of metabolic syndrome and prostate cancer.
Gacci M; Russo GI; De Nunzio C; Sebastianelli A; Salvi M; Vignozzi L; Tubaro A; Morgia G; Serni S
Prostate Cancer Prostatic Dis; 2017 Jun; 20(2):146-155. PubMed ID: 28220805
[TBL] [Abstract][Full Text] [Related]
15. Telomere length in Parkinson's disease: A meta-analysis.
Forero DA; González-Giraldo Y; López-Quintero C; Castro-Vega LJ; Barreto GE; Perry G
Exp Gerontol; 2016 Mar; 75():53-5. PubMed ID: 26772888
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of Telomere Length in Alzheimer's Disease.
Forero DA; González-Giraldo Y; López-Quintero C; Castro-Vega LJ; Barreto GE; Perry G
J Gerontol A Biol Sci Med Sci; 2016 Aug; 71(8):1069-73. PubMed ID: 27091133
[TBL] [Abstract][Full Text] [Related]
17. Perceived stress and telomere length: A systematic review, meta-analysis, and methodologic considerations for advancing the field.
Mathur MB; Epel E; Kind S; Desai M; Parks CG; Sandler DP; Khazeni N
Brain Behav Immun; 2016 May; 54():158-169. PubMed ID: 26853993
[TBL] [Abstract][Full Text] [Related]
18. The association between telomere length and cancer risk in population studies.
Zhu X; Han W; Xue W; Zou Y; Xie C; Du J; Jin G
Sci Rep; 2016 Feb; 6():22243. PubMed ID: 26915412
[TBL] [Abstract][Full Text] [Related]
19. The association between post-traumatic stress disorder and shorter telomere length: A systematic review and meta-analysis.
Li X; Wang J; Zhou J; Huang P; Li J
J Affect Disord; 2017 Aug; 218():322-326. PubMed ID: 28486180
[TBL] [Abstract][Full Text] [Related]
20. Positive surgical margin is associated with biochemical recurrence risk following radical prostatectomy: a meta-analysis from high-quality retrospective cohort studies.
Zhang L; Wu B; Zha Z; Zhao H; Jiang Y; Yuan J
World J Surg Oncol; 2018 Jul; 16(1):124. PubMed ID: 29970100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
